CXCL12 and acute myeloid leukemia: This is consistent with our previous observation that vorinostat or panobinostat pre-treatment of osteoblasts inhibited their ability to protect AML cells from SDF-1-induced apoptosis via activation of a Nherf1-PP1a-TAZ signaling pathway [30].